Plenary Lecture:

Yu-Shan Lin, PhD

Professor and Department Chair, Chemistry @ Tufts University

Structure Prediction of Cyclic Peptides Via Molecular Dynamics and Machine Learning 

Plenary Lecture:

Gregory L. Verdine, PhD

Ervin Professor of Chemistry, Department of Chemistry & Chemical Biology @ Harvard University 

The Radicalization of Drug Discovery

Abba Leffler, PhD

Senior Principal Scientist, Computational Chemistry @ Schrödinger

From Computer Aided to Computer Accelerated Drug Design

Anne Marinier, PhD

Director of the Discovery Unit, IRIC; Prof. Department of Pharmacology & Physiology, University de Montreal

UM171: From Stem Cell Expansion to CoREST Degradation - A Clinical Molecular Glue Story

Ludivine Moine, MSc

Principal Scientist @ Blueprint Medicines

Design and Synthesis of BLU-654, a Potent and Selective Mutant KIT V654A Inhibitor for the Treatment of imatinib-resistant GIST

Taylor Quinn, PhD

Associate Principal Scientist @ AstraZeneca

Accelerated Discovery of a Carbamate Scaffold Cbl-b Inhibitor Using Generative Models and Structure-Based Drug Design

Rebecca Swett, PhD

Director of Computational Chemistry Innovation @ X-Chem

Chemomics Applied: What leveraging a complete DEL dataset looks like in practice 

Momar Toure, PhD

Director, Medicinal Chemistry @ MOMA Therapeutics

Discovery and Optimization of a Novel Covalent WRN Helicase Inhibitor Series

Murray Wan, PhD

Principal Scientist @ Mariana Oncology a Novartis Company

Discovery of a DLL3-Targeting Macrocyclic Peptide Radioligand Therapy for the Treatment of SCLC

Elsie Yu, PhD

Associate Principal Scientist @ Merck

IL4i1 Inhibitors from Target Validation Through to First-In-Human Studies in Cancer Patients